| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adrenoceptor alpha 1B | 0.686 | 0.500 | 0.14 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta2 | 0.619 | 0.500 | 0.85 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glutamate metabotropic receptor 3 | 0.606 | 0.538 | 0.78 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
VGF nerve growth factor inducible | 0.626 | 0.538 | 0.57 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1993 | 2007 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
group | 0.330 | None | 1.000 | 5 | 0 | 2000 | 2012 | ||||||||
|
adenylate cyclase 8 | 0.705 | 0.577 | 1.8E-06 |
|
group | 0.510 | None | 1.000 | 4 | 0 | 2009 | 2013 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
group | 0.340 | None | 0.750 | 4 | 0 | 1998 | 2004 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
vacuolar protein sorting 13 homolog A | 0.650 | 0.577 | 9.3E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
potassium two pore domain channel subfamily K member 9 | 0.615 | 0.577 | 0.96 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
prepronociceptin | 0.603 | 0.577 | 1.5E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
dystrobrevin binding protein 1 | 0.588 | 0.615 | 6.8E-06 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2004 | 2011 | ||||||||
|
adrenoceptor alpha 2A | 0.578 | 0.615 | 8.2E-04 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
discs large MAGUK scaffold protein 3 | 0.544 | 0.615 | 1.00 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2010 | ||||||||
|
adenylate cyclase 3 | 0.678 | 0.615 | 2.0E-11 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
D-amino acid oxidase | 0.636 | 0.615 | 6.2E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
group | 0.390 | None | 0.800 | 5 | 0 | 2005 | 2018 | ||||||||
|
discs large MAGUK scaffold protein 4 | 0.595 | 0.654 | 1.00 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2004 | 2012 |